Oncternal Therapeutics (ONCT) Return on Equity (ROE) (2019 - 2024)
Oncternal Therapeutics (ONCT) Return on Equity (ROE) from Jun 30, 2019 to Sep 30, 2024. The TTM Oncternal Therapeutics (ONCT) Return on Equity (ROE) is -92.52%. You can export chart.
Annual ROE
Quarterly ROE
Annual Return on Equity (ROE) change of Oncternal Therapeutics (ONCT)
| Year | Return on Equity (ROE) | Change |
|---|---|---|
| 2023 | -125.77% | +73.61% |
| 2022 | -72.45% | +103.76% |
| 2021 | -35.55% | +133.07% |
| 2020 | -15.25% | -93.62% |
| 2019 | -238.92% | N/A |